{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:57:57Z","timestamp":1790013477910,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202002030101"],"award-info":[{"award-number":["202002030101"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various biomarkers associated with sarcopenia have been identified. However, there is a scarcity of studies exploring and validating biomarkers in individuals with age-related sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to investigate the proteome and identify potential biomarkers for age-related sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Proteomic analysis and experimental validation were conducted using plasma from hospitalized older adults. Sarcopenia diagnosis was based on the Asian Working Group for Sarcopenia 2019 criteria. Data-independent acquisition-based proteomics was performed on plasma from 60 participants, with 30 diagnosed with sarcopenia and 30 without sarcopenia. Differentially expressed proteins (DEPs) were selected and evaluated by Receiver Operating Characteristic (ROC) analysis. Biomarker candidates were further quantitatively validated by enzyme-linked immunosorbent assay (ELISA) utilizing plasma from 6 participants with sarcopenia and 6 without sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 39 DEPs were identified and 12 DEPs were selected for ROC analysis. 8 DEPs were included for ELISA validation based on their predictive performance. Paraoxonase-3 (PON3) consistently showed down-regulation in the sarcopenic group across both methodologies. Insulin-like growth factor-binding protein-2 (IGFBP2) showed inconsistency in the sarcopenic group, with up-regulation observed in proteomic analysis but down-regulation in ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Decline in PON3 may result in an overload of oxidative stress in skeletal muscles and contribute to sarcopenia. Protein modifications of IGFBP2 might exhibit during sarcopenia pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma proteins are implicated in sarcopenia pathogenesis. PON3 is highlighted as a potential biomarker for patients with age-related sarcopenia. Further studies are imperative to gain an in-depth understanding of PON3 and IGFBP2.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-024-02903-7","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T21:45:35Z","timestamp":1735249535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8555-6641","authenticated-orcid":false,"given":"Qinqing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6216-1688","authenticated-orcid":false,"given":"Kangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7086-4677","authenticated-orcid":false,"given":"Liwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4537-4085","authenticated-orcid":false,"given":"Lichang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-9092","authenticated-orcid":false,"given":"Dake","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0971-1867","authenticated-orcid":false,"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1540-631X","authenticated-orcid":false,"given":"Lishu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"2903_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"2903_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13243","author":"C Beaudart","year":"2023","unstructured":"Beaudart C, Demonceau C, Reginster JY et al (2023) Sarcopenia and health-related quality of life: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.13243","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12997","author":"C Ye","year":"2022","unstructured":"Ye C, Zheng X, Aihemaitijiang S et al (2022) Sarcopenia and catastrophic health expenditure by socio-economic groups in China: an analysis of household-based panel data. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12997","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101270","author":"D Liu","year":"2024","unstructured":"Liu D, Wang S, Liu S et al (2024) Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies. Mol Aspects Med. https:\/\/doi.org\/10.1016\/j.mam.2024.101270","journal-title":"Mol Aspects Med"},{"key":"2903_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.05.016","author":"SY Tsai","year":"2024","unstructured":"Tsai SY (2024) Lost in translation: challenges of current pharmacotherapy for sarcopenia. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2024.05.016","journal-title":"Trends Mol Med"},{"key":"2903_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)31138-9","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9","journal-title":"Lancet"},{"key":"2903_CR7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00061.2017","author":"L Larsson","year":"2019","unstructured":"Larsson L, Degens H, Li M et al (2019) Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00061.2017","journal-title":"Physiol Rev"},{"key":"2903_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12901","author":"CW Li","year":"2022","unstructured":"Li CW, Yu K, Shyh-Chang N et al (2022) Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12901","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105115","author":"HE Shin","year":"2023","unstructured":"Shin HE, Won CW, Kim M (2023) Development of multiple biomarker panels for prediction of sarcopenia in community-dwelling older adults. Arch Gerontol Geriatr. https:\/\/doi.org\/10.1016\/j.archger.2023.105115","journal-title":"Arch Gerontol Geriatr"},{"key":"2903_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102148","author":"R Lian","year":"2024","unstructured":"Lian R, Liu Q, Jiang G et al (2024) Blood biomarkers for sarcopenia: a systematic review and meta-analysis of diagnostic test accuracy studies. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2023.102148","journal-title":"Ageing Res Rev"},{"key":"2903_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13567","author":"WH Hsu","year":"2024","unstructured":"Hsu WH, Wang SY, Chao YM et al (2024) Novel metabolic and lipidomic biomarkers of sarcopenia. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.13567","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155972","author":"Y Zou","year":"2024","unstructured":"Zou Y, Tang X, Yang S et al (2024) New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2024.155972","journal-title":"Metabolism"},{"key":"2903_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111924","author":"HE Shin","year":"2022","unstructured":"Shin HE, Won CW, Kim M (2022) Metabolomic profiles to explore biomarkers of severe sarcopenia in older men: a pilot study. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2022.111924","journal-title":"Exp Gerontol"},{"key":"2903_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115877","author":"HW Jung","year":"2021","unstructured":"Jung HW, Park JH, Kim DA et al (2021) Association between serum FGF21 level and sarcopenia in older adults. Bone. https:\/\/doi.org\/10.1016\/j.bone.2021.115877","journal-title":"Bone"},{"key":"2903_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12417","author":"CW Li","year":"2019","unstructured":"Li CW, Yu K, Shyh-Chang N et al (2019) Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12417","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101576","author":"JC Liu","year":"2022","unstructured":"Liu JC, Dong SS, Shen H et al (2022) Multi-omics research in sarcopenia: current progress and future prospects. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2022.101576","journal-title":"Ageing Res Rev"},{"key":"2903_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13548-9","author":"SN Dlamini","year":"2022","unstructured":"Dlamini SN, Norris SA, Mendham AE et al (2022) Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-13548-9","journal-title":"Sci Rep"},{"key":"2903_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad024","author":"W Jiang","year":"2023","unstructured":"Jiang W, Zhan W, Zhou L et al (2023) Potential therapeutic targets for sarcopenia identified by Mendelian randomisation. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afad024","journal-title":"Age Ageing"},{"key":"2903_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13539","author":"P Aparicio","year":"2024","unstructured":"Aparicio P, Navarrete-Villanueva D, G\u00f3mez-Cabello A et al (2024) Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.13539","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12733","author":"MT Huemer","year":"2021","unstructured":"Huemer MT, Bauer A, Petrera A et al (2021) Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4\/FF4 study. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12733","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49874","author":"C Ubaida-Mohien","year":"2019","unstructured":"Ubaida-Mohien C, Lyashkov A, Gonzalez-Freire M et al (2019) Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondria. Elife. https:\/\/doi.org\/10.7554\/eLife.49874","journal-title":"Elife"},{"key":"2903_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100712","author":"R Lou","year":"2024","unstructured":"Lou R, Shui W (2024) Acquisition and analysis of DIA-based proteomic data: a comprehensive survey in 2023. Mol Cell Proteomics. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100712","journal-title":"Mol Cell Proteomics"},{"key":"2903_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100661","author":"O Karayel","year":"2022","unstructured":"Karayel O, Virreira Winter S, Padmanabhan S et al (2022) Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100661","journal-title":"Cell Rep Med"},{"key":"2903_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123880","author":"H Li","year":"2022","unstructured":"Li H, Xu Y, Zhou X et al (2022) DIA-based proteomic analysis of plasma protein profiles in patients with severe acute pancreatitis. Molecules. https:\/\/doi.org\/10.3390\/molecules27123880","journal-title":"Molecules"},{"key":"2903_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1004015","author":"C Wang","year":"2022","unstructured":"Wang C, Liu G, Liu Y et al (2022) Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.1004015","journal-title":"Front Oncol"},{"key":"2903_CR26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-anchem-061516-045357","author":"JA Ankney","year":"2018","unstructured":"Ankney JA, Muneer A, Chen X (2018) Relative and absolute quantitation in mass spectrometry-based proteomics. Annu Rev Anal Chem (Palo Alto Calif). https:\/\/doi.org\/10.1146\/annurev-anchem-061516-045357","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"2903_CR27","doi-asserted-by":"publisher","DOI":"10.2147\/jhc.S325629","author":"YQ Che","year":"2021","unstructured":"Che YQ, Zhang Y, Li HB et al (2021) Serum KLKB1 as a potential prognostic biomarker for hepatocellular carcinoma based on data-independent acquisition and parallel reaction monitoring. J Hepatocell Carcinoma. https:\/\/doi.org\/10.2147\/jhc.S325629","journal-title":"J Hepatocell Carcinoma"},{"key":"2903_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2023.104995","author":"S Ji","year":"2023","unstructured":"Ji S, Liu Y, Yan L et al (2023) DIA-based analysis of the menstrual blood proteome identifies association between CXCL5 and IL1RN and endometriosis. J Proteomics. https:\/\/doi.org\/10.1016\/j.jprot.2023.104995","journal-title":"J Proteomics"},{"key":"2903_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1301227","author":"Q Cao","year":"2023","unstructured":"Cao Q, Zhu H, Xu W et al (2023) Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1301227","journal-title":"Front Immunol"},{"key":"2903_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05844-2","author":"J Wu","year":"2022","unstructured":"Wu J, Cao L, Wang J et al (2022) Characterization of serum protein expression profiles in the early sarcopenia older adults with low grip strength: a cross-sectional study. BMC Musculoskelet Disord. https:\/\/doi.org\/10.1186\/s12891-022-05844-2","journal-title":"BMC Musculoskelet Disord"},{"key":"2903_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.014","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG et al (2014) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014","journal-title":"Int J Surg"},{"key":"2903_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1279448","author":"J Zhou","year":"2023","unstructured":"Zhou J, Liu J, Lin Q et al (2023) Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1279448","journal-title":"Front Pharmacol"},{"key":"2903_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05015-z","author":"ZM Pan","year":"2024","unstructured":"Pan ZM, Zeng J, Li T et al (2024) Age-adjusted Charlson comorbidity index is associated with the risk of osteoporosis in older fall-prone men: a retrospective cohort study. BMC Geriatr. https:\/\/doi.org\/10.1186\/s12877-024-05015-z","journal-title":"BMC Geriatr"},{"key":"2903_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu031","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY et al (2014) InterProScan 5: genome-scale protein function classification. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btu031","journal-title":"Bioinformatics"},{"key":"2903_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn923","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkn923","journal-title":"Nucleic Acids Res"},{"key":"2903_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030590","author":"CJ Mohammed","year":"2022","unstructured":"Mohammed CJ, Lamichhane S, Connolly JA et al (2022) A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox11030590","journal-title":"Antioxidants (Basel)"},{"key":"2903_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.05.036","author":"CE Furlong","year":"2016","unstructured":"Furlong CE, Marsillach J, Jarvik GP et al (2016) Paraoxonases-1, -2 and -3: What are their functions? Chem Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2016.05.036","journal-title":"Chem Biol Interact"},{"key":"2903_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.11.013","author":"T Bacchetti","year":"2019","unstructured":"Bacchetti T, Ferretti G, Sahebkar A (2019) The role of paraoxonase in cancer. Semin Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.013","journal-title":"Semin Cancer Biol"},{"key":"2903_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086881","author":"FK Khalaf","year":"2023","unstructured":"Khalaf FK, Connolly J, Khatib-Shahidi B et al (2023) Paraoxonases at the heart of neurological disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24086881","journal-title":"Int J Mol Sci"},{"key":"2903_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.21.4.542","author":"ST Reddy","year":"2001","unstructured":"Reddy ST, Wadleigh DJ, Grijalva V et al (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/01.atv.21.4.542","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2903_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8050118","author":"D Levy","year":"2019","unstructured":"Levy D, Reichert CO, Bydlowski SP (2019) Paraoxonases activities and polymorphisms in elderly and old-age diseases: an overview. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox8050118","journal-title":"Antioxidants (Basel)"},{"key":"2903_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100982","author":"J Luo","year":"2020","unstructured":"Luo J, Mills K, le Cessie S et al (2020) Ageing, age-related diseases and oxidative stress: what to do next? Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2019.100982","journal-title":"Ageing Res Rev"},{"key":"2903_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030552","author":"YA Hajam","year":"2022","unstructured":"Hajam YA, Rani R, Ganie SY et al (2022) Oxidative stress in human pathology and aging: molecular mechanisms and perspectives. Cells. https:\/\/doi.org\/10.3390\/cells11030552","journal-title":"Cells"},{"key":"2903_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12339","author":"R Qaisar","year":"2018","unstructured":"Qaisar R, Bhaskaran S, Premkumar P et al (2018) Oxidative stress-induced dysregulation of excitation-contraction coupling contributes to muscle weakness. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12339","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR45","doi-asserted-by":"publisher","DOI":"10.12659\/msm.898231","author":"Y Li","year":"2016","unstructured":"Li Y, Liang G, Shi L et al (2016) Paraoxonase-1 (PON1) rs662 polymorphism and its association with serum lipid levels and longevity in the Bama Zhuang population. Med Sci Monit. https:\/\/doi.org\/10.12659\/msm.898231","journal-title":"Med Sci Monit"},{"key":"2903_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148510","author":"V Erdman","year":"2024","unstructured":"Erdman V, Tuktarova I, Nasibullin T et al (2024) Polygenic markers of survival and longevity in the antioxidant genes PON1, PON2, MTHFR, MSRA, SOD1, NQO1, and CAT in a 20-year follow-up study in the population from the Volga-Ural region. Gene. https:\/\/doi.org\/10.1016\/j.gene.2024.148510","journal-title":"Gene"},{"key":"2903_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.10.008","author":"NJ Haywood","year":"2019","unstructured":"Haywood NJ, Slater TA, Matthews CJ et al (2019) The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes. Mol Metab. https:\/\/doi.org\/10.1016\/j.molmet.2018.10.008","journal-title":"Mol Metab"},{"key":"2903_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12692","author":"J Dong","year":"2021","unstructured":"Dong J, Yu J, Li Z et al (2021) Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting. J Cachexia Sarcopenia Muscle. https:\/\/doi.org\/10.1002\/jcsm.12692","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2903_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1666","author":"NK Lebrasseur","year":"2012","unstructured":"Lebrasseur NK, Achenbach SJ, Melton LJ 3rd et al (2012) Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.1666","journal-title":"J Bone Miner Res"},{"key":"2903_CR50","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480627","author":"AW van den Beld","year":"2003","unstructured":"van den Beld AW, Blum WF, Pols HA et al (2003) Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.0.1480627","journal-title":"Eur J Endocrinol"},{"key":"2903_CR51","doi-asserted-by":"publisher","DOI":"10.1530\/eje-18-0422","author":"AW van den Beld","year":"2019","unstructured":"van den Beld AW, Carlson OD, Doyle ME et al (2019) IGFBP-2 and aging: a 20-year longitudinal study on IGFBP-2, IGF-I, BMI, insulin sensitivity and mortality in an aging population. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje-18-0422","journal-title":"Eur J Endocrinol"},{"key":"2903_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad265","author":"DS Evans","year":"2024","unstructured":"Evans DS, Young D, Tanaka T et al (2024) Proteomic analysis of the senescence-associated secretory phenotype: GDF-15, IGFBP-2, and Cystatin-C are associated with multiple aging traits. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glad265","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2903_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/08977194.2023.2259497","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huang J, Zhang F et al (2023) Knock-down of IGFBP2 ameliorates lung fibrosis and inflammation in rats with severe pneumonia through STAT3 pathway. Growth Factors. https:\/\/doi.org\/10.1080\/08977194.2023.2259497","journal-title":"Growth Factors"},{"key":"2903_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111409","author":"W Wang","year":"2024","unstructured":"Wang W, Ye J, Xu L et al (2024) The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.111409","journal-title":"Int Immunopharmacol"},{"key":"2903_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13974","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jin L, Hua X et al (2023) SARM1 promotes the neuroinflammation and demyelination through IGFBP2\/NF-\u03baB pathway in experimental autoimmune encephalomyelitis mice. Acta Physiol (Oxf). https:\/\/doi.org\/10.1111\/apha.13974","journal-title":"Acta Physiol (Oxf)"},{"key":"2903_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031133","author":"H Boughanem","year":"2021","unstructured":"Boughanem H, Yubero-Serrano EM, L\u00f3pez-Miranda J et al (2021) Potential role of insulin growth-factor-binding protein 2 as therapeutic target for obesity-related insulin resistance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22031133","journal-title":"Int J Mol Sci"},{"key":"2903_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1154-2","author":"T Li","year":"2020","unstructured":"Li T, Forbes ME, Fuller GN et al (2020) IGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene. https:\/\/doi.org\/10.1038\/s41388-020-1154-2","journal-title":"Oncogene"},{"key":"2903_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1126093","author":"W Wang","year":"2023","unstructured":"Wang W, Yu K, Zhao SY et al (2023) The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2023.1126093","journal-title":"Front Cardiovasc Med"},{"key":"2903_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7220","author":"NJ Ashton","year":"2019","unstructured":"Ashton NJ, Nevado-Holgado AJ, Barber IS et al (2019) A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aau7220","journal-title":"Sci Adv"},{"key":"2903_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2016.02.006","author":"QH Tong","year":"2016","unstructured":"Tong QH, Tao T, Xie LQ et al (2016) ELISA-PLA: a novel hybrid platform for the rapid, highly sensitive and specific quantification of proteins and post-translational modifications. Biosens Bioelectron. https:\/\/doi.org\/10.1016\/j.bios.2016.02.006","journal-title":"Biosens Bioelectron"},{"key":"2903_CR61","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M800238-MCP200","author":"T Fortin","year":"2009","unstructured":"Fortin T, Salvador A, Charrier JP et al (2009) Clinical quantitation of prostate-specific antigen biomarker in the low nanogram\/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol Cell Proteomics. https:\/\/doi.org\/10.1074\/mcp.M800238-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"2903_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204366109","author":"T Shi","year":"2012","unstructured":"Shi T, Fillmore TL, Sun X et al (2012) Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma\/serum. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1204366109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2903_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14134","author":"CL Neal","year":"2024","unstructured":"Neal CL, Kronert WA, Camillo JRT et al (2024) Aging-affiliated post-translational modifications of skeletal muscle myosin affect biochemical properties, myofibril structure, muscle function, and proteostasis. Aging Cell. https:\/\/doi.org\/10.1111\/acel.14134","journal-title":"Aging Cell"},{"key":"2903_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12307","author":"M Li","year":"2015","unstructured":"Li M, Ogilvie H, Ochala J et al (2015) Aberrant post-translational modifications compromise human myosin motor function in old age. Aging Cell. https:\/\/doi.org\/10.1111\/acel.12307","journal-title":"Aging Cell"},{"key":"2903_CR65","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700027-MCP200","author":"ME Graham","year":"2007","unstructured":"Graham ME, Kilby DM, Firth SM et al (2007) The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5. Mol Cell Proteomics. https:\/\/doi.org\/10.1074\/mcp.M700027-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"2903_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2013.11.006","author":"M \u0160underi\u0107","year":"2014","unstructured":"\u0160underi\u0107 M, \u0110ukanovi\u0107 B, Malenkovi\u0107 V et al (2014) Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer. Exp Mol Pathol. https:\/\/doi.org\/10.1016\/j.yexmp.2013.11.006","journal-title":"Exp Mol Pathol"},{"key":"2903_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.03.003","author":"M \u0160underi\u0107","year":"2015","unstructured":"\u0160underi\u0107 M, Malenkovi\u0107 V, Nedi\u0107 O (2015) Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor. Exp Mol Pathol. https:\/\/doi.org\/10.1016\/j.yexmp.2015.03.003","journal-title":"Exp Mol Pathol"},{"key":"2903_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2014.08.002","author":"M Sunderi\u0107","year":"2014","unstructured":"Sunderi\u0107 M, Mihailovi\u0107 N, Nedi\u0107 O (2014) Protein molecular forms of insulin-like growth factor binding protein-2 change with aging. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2014.08.002","journal-title":"Exp Gerontol"},{"key":"2903_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.003","author":"M Moqri","year":"2023","unstructured":"Moqri M, Herzog C, Poganik JR et al (2023) Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. https:\/\/doi.org\/10.1016\/j.cell.2023.08.003","journal-title":"Cell"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-024-02903-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T22:18:39Z","timestamp":1735251519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-024-02903-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2903"],"URL":"https:\/\/doi.org\/10.1007\/s40520-024-02903-7","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"29 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the 1964 Helsinki Declaration and its later amendments.\u00a0This study was approved by the Ethics Committee of Guangdong Provincial People\u2019s Hospital in Guangzhou, China (approval no. GDREC20198345H(RI)). All procedures followed the local legislation and institutional requirements. All participants were informed and provided written informed consents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consents were obtained\u00a0from all participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"13"}}